Figure 4, Distribution of Estimated Values of HbA1c End Point From Regression After Adjusting for Age, Baseline HbA1c, Assigned Treatment, SAT Perceived Effectiveness, and SES Distress Subscales - Benchmarking the Comparative Effectiveness of Diabetes Treatments Using Patient-Reported Outcomes and Socio-Demographic Factors

From: Benchmarking the Comparative Effectiveness of Diabetes Treatments Using Patient-Reported Outcomes and Socio-Demographic Factors

Cover of Benchmarking the Comparative Effectiveness of Diabetes Treatments Using Patient-Reported Outcomes and Socio-Demographic Factors

Benchmarking the Comparative Effectiveness of Diabetes Treatments Using Patient-Reported Outcomes and Socio-Demographic Factors [Internet].

Testa MA, Su M, Turchin A, et al.

Washington (DC): Patient-Centered Outcomes Research Institute (PCORI); 2021 Mar.

This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License which permits noncommercial use and distribution provided the original author(s) and source are credited. (See https://creativecommons.org/licenses/by-nc-nd/4.0/

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

Figure 4Distribution of Estimated Values of HbA1c End Point From Regression After Adjusting for Age, Baseline HbA1c, Assigned Treatment, SAT Perceived Effectiveness, and SES Distress Subscalesa

Figure 4Distribution of Estimated Values of HbA_1c End Point From Regression After Adjusting for Age, Baseline HbA_1c, Assigned Treatment, SAT Perceived Effectiveness, and SES Distress Subscales^{^a}